Form 4: Bicycle Therapeutics CSO Sells Shares to Cover Tax Obligations
SEC Form 4
Nicholas Keen, Chief Scientific Officer of Bicycle Therapeutics PLC, sold 779 ordinary shares to cover tax withholding obligations related to the vesting and settlement of RSUs.
Summary
- Nicholas Keen, the Chief Scientific Officer of Bicycle Therapeutics PLC, reported a transaction on July 3, 2024.
- He sold 779 ordinary shares at a weighted average price of $19.64 to cover statutory tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).
- The sale was mandated by his award agreement, which requires a 'sell to cover' transaction to satisfy tax obligations.
- Following the transaction, Keen directly owns 62,024 ordinary shares and indirectly owns 7,000 ordinary shares through a GRAT (Grantor Retained Annuity Trust).
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction is a routine sale of shares to cover tax obligations.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when stock options or restricted stock units vest.
Key Dates
| Date | Description |
|---|---|
| 07/03/2024 | Date of the transaction: sale of ordinary shares. |
| 07/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.